Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 72 Neoplasms 64 Prostatic Neoplasms 45 Colorectal Neoplasms 42 Lung Neoplasms 38 Carcinoma, Non-Small-Cell Lung 26 Pancreatic Neoplasms 21 Neoplasm Metastasis 20 Hematologic Neoplasms 20 Head and Neck Neoplasms 20 Urinary Bladder Neoplasms 15 Ovarian Neoplasms 14 Multiple Myeloma 11 Motor Activity 11 Leukemia, Myeloid, Acute 11 Stomach Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Uterine Cervical Neoplasms 9 Triple Negative Breast Neoplasms 9 Glioblastoma 9 Colonic Neoplasms 9 Hematopoietic and Lymphatic System Neoplasm 8 Glioma 8 Gastrointestinal Neoplasms 8 Carcinoma, Renal Cell 8 COVID-19 8 Anxiety Disorders 8 Anatomic Stage I Breast Cancer AJCC v8 8 Rectal Neoplasms 7 Melanoma 7

Interventions

Pyridoxine 3 Celecoxib 2 Capecitabine 2 tegafur-gimeracil-oteracil 1 mecobalamin 1 liposomal doxorubicin 1 Vitamin B 6 1 Urea 1 Tobacco Use Cessation Devices 1 Standard of Care 1 S 1 (combination) 1 Radiotherapy 1 Low-Level Light Therapy 1 Diclofenac 1 Brimonidine Tartrate 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hand-Foot Syndrome × Standard of Care × Clear all

NCT05755646 2026-05-06

WIn-HFS

University Hospital Tuebingen

Phase NA Completed

Breast Neoplasms, Hand-Foot Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡